Impact of morbid obesity (BMI > 40 kg/m


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
03 2019
Historique:
received: 20 08 2018
revised: 01 02 2019
accepted: 03 02 2019
pubmed: 11 2 2019
medline: 14 5 2020
entrez: 11 2 2019
Statut: ppublish

Résumé

The negative effects of obesity on the health and quality of life of those afflicted has become an important public concern. Previous studies have shown an association between obesity and higher rates of complications and unfavorable outcomes following spine surgery. This study is to identify peri- and postoperative complication rates as well as short-term and long-term outcomes in morbidly obese patients who underwent minimally invasive transforaminal lumbar interbody fusion (MIS TLIF) in comparison to age-matched normal-weight patients. We retrospectively reviewed medical records for all adult patients with a body mass index (BMI) ≥40 kg/m We identified 14 patients with a BMI ≥ 40 kg/m MIS TLIF is technically feasible in morbidly obese patients with no evidence of higher complication rates among this demographic compared to normal-weight individuals when followed-up in the short-term (<30 days); however, available long-term follow-up data suggest a higher complication rate, greater need for analgesics and a much lower reduction of lower back pain in the morbidly obese group.

Identifiants

pubmed: 30739072
pii: S0303-8467(19)30028-9
doi: 10.1016/j.clineuro.2019.02.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-85

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Marie T Krüger (MT)

Department of Neurosurgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Yashar Naseri (Y)

Department of Neurosurgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Marc Hohenhaus (M)

Department of Neurosurgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Ulrich Hubbe (U)

Department of Neurosurgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Christoph Scholz (C)

Department of Neurosurgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Jan-Helge Klingler (JH)

Department of Neurosurgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany. Electronic address: jan-helge.klingler@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH